Drugs / Platelet rich Fibrin (PRF)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07294521 | Dec 2025 → Apr 2026 overdue | ulcer of lower limbs | Pak Emirates Military Hospital | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07022860 | Sep 2024 → Jan 2025 | — | Zahedan University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet-rich fibrin (PRF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07022860 ↗ |
| Known as | PRF | “Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers” NCT07294521 ↗ |